Companion Diagnostics Development Services Market is estimated to be worth over USD 800 million in 2030

RootsAnalysis is pleased to announce the publication of its recent study, titled, “Companion Diagnostics DevelopmentServices Market,2020-2030”

Thereport features an extensive study of the current market landscape, offering aninformed opinion on the likely adoption of diagnostic development services overthe next decade. It features an in-depth analysis, highlighting thecapabilities of the various stakeholders in this domain. In addition to otherelements, the study includes:

·       A detailed assessment of the current marketlandscape of more than 180 companies offering companion diagnostics services.

·       Tabulated profiles of companion diagnosticsservice providers (shortlisted on the basis of the number of services offered).

·       An analysis of the partnerships that havebeen established in this domain, in the recent past.

·       A list of stakeholders generated based on adetailed analysis of a set of relevant parameters, which are anticipated topartner with companion diagnostics services providers in the foreseen future.

·       A detailed competitiveness analysis ofcompanion diagnostics services providers, featuring insightful pictorialsummaries and representations.

·       A comparative analysis of the needs ofdifferent stakeholders involved in this domain.

·       A discussion on various steps of thedevelopment operations of a companion diagnostic and the cost requirementsacross each of the stages.

·       An analysis of completed, ongoing and plannedclinical trials featuring disease-specific biomarkers.

Formore information, please visit https://www.rootsanalysis.com/reports/297/request-sample.html

Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)

Typeof Services

·       Feasibility Studies

·       Assay Development

·       Analytical Validation

·       Clinical Validation

·       Manufacturing

Typeof Analytical Technique

·       in situ hybridization / Immunohistochemistry

·       Next Generation Sequencing

·       Polymerase Chain Reaction

·       Others

KeyGeographical Region

·       North America

·       Europe

·       Asia-Pacific and the Rest of the World

Transcriptsof interviews held with the following senior level representatives ofstakeholder companies

·       Anton Iliuk (President, Chief TechnologyOfficer Tymora Analytical Operations)

·       Paul Kortschak (Senior Vice President,Novodiax)

·       Pablo Ortiz (Chief Executive Officer, OWLMetabolomics)

·       Lawrence M. Weiss (Chief Scientific Officer,NeoGenomics Laboratories)

Keycompanies covered in the report

·       Almac Diagnostic Services

·       Asuragen

·       BARD1 Life Sciences

·       BioMarCare Technologies

·       Covance

·       Gencurix

·       Geneuity

·       Leica Biosystems

·       Macrogen

·       MD Biosciences

·       R-Biopharm

·       ResearchDx

·       Tepnel Pharma Services

Requestfor C:

https://www.rootsanalysis.com/reports/297/request-customization.html    

AboutRoots Analysis

RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growing businessneeds, get in touch at info@rootsanalysis.com

ContactInformation

RootsAnalysis Private Limited

GauravChaudhary

+1(415) 800 3415